Neuronetics Net Income
| STIM Stock | USD 1.56 0.14 9.86% |
As of the 8th of February, Neuronetics secures the Mean Deviation of 5.56, standard deviation of 7.04, and Risk Adjusted Performance of (0.06). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neuronetics, as well as the relationship between them. Please verify Neuronetics market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Neuronetics is priced some-what accurately, providing market reflects its recent price of 1.56 per share. Please also check out Neuronetics jensen alpha, which is currently at (0.91) to check the company can sustain itself at a future point.
Neuronetics Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.302 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -39.4 M | -41.3 M | |
| Net Loss | -33.4 M | -35.1 M | |
| Net Loss | -39.4 M | -41.3 M | |
| Net Loss | (1.24) | (1.30) | |
| Net Income Per E B T | 1.15 | 1.10 |
Neuronetics | Net Income | Build AI portfolio with Neuronetics Stock |
Evaluating Neuronetics's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Neuronetics's fundamental strength.
Latest Neuronetics' Net Income Growth Pattern
Below is the plot of the Net Income of Neuronetics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Neuronetics financial statement analysis. It represents the amount of money remaining after all of Neuronetics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Neuronetics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Neuronetics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (43.73 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Neuronetics Net Income Regression Statistics
| Arithmetic Mean | (23,422,427) | |
| Coefficient Of Variation | (52.53) | |
| Mean Deviation | 10,903,814 | |
| Median | (24,097,000) | |
| Standard Deviation | 12,303,013 | |
| Sample Variance | 151.4T | |
| Range | 32.5M | |
| R-Value | (0.94) | |
| Mean Square Error | 18.3T | |
| R-Squared | 0.89 | |
| Slope | (2,293,877) | |
| Total Sum of Squares | 2421.8T |
Neuronetics Net Income History
Other Fundumenentals of Neuronetics
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Neuronetics Net Income component correlations
Neuronetics Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Neuronetics is extremely important. It helps to project a fair market value of Neuronetics Stock properly, considering its historical fundamentals such as Net Income. Since Neuronetics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Neuronetics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Neuronetics' interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could Neuronetics diversify its offerings? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Neuronetics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth 1.013 | Return On Assets | Return On Equity |
Neuronetics's market price often diverges from its book value, the accounting figure shown on Neuronetics's balance sheet. Smart investors calculate Neuronetics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Neuronetics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Neuronetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Neuronetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Neuronetics.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in Neuronetics on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Neuronetics or generate 0.0% return on investment in Neuronetics over 90 days. Neuronetics is related to or competes with Prenetics Global, Nyxoah, Atlantic International, OmniAb, Perspective Therapeutics, OraSure Technologies, and Profound Medical. Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients w... More
Neuronetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Neuronetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Neuronetics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 34.69 | |||
| Value At Risk | (9.52) | |||
| Potential Upside | 10.55 |
Neuronetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neuronetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Neuronetics' standard deviation. In reality, there are many statistical measures that can use Neuronetics historical prices to predict the future Neuronetics' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.91) | |||
| Total Risk Alpha | (1.33) | |||
| Treynor Ratio | (0.18) |
Neuronetics February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.17) | |||
| Mean Deviation | 5.56 | |||
| Coefficient Of Variation | (1,130) | |||
| Standard Deviation | 7.04 | |||
| Variance | 49.55 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.91) | |||
| Total Risk Alpha | (1.33) | |||
| Treynor Ratio | (0.18) | |||
| Maximum Drawdown | 34.69 | |||
| Value At Risk | (9.52) | |||
| Potential Upside | 10.55 | |||
| Skewness | 0.3426 | |||
| Kurtosis | 0.3853 |
Neuronetics Backtested Returns
Neuronetics has Sharpe Ratio of -0.0378, which conveys that the firm had a -0.0378 % return per unit of risk over the last 3 months. Neuronetics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neuronetics' Risk Adjusted Performance of (0.06), standard deviation of 7.04, and Mean Deviation of 5.56 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 3.48, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Neuronetics will likely underperform. At this point, Neuronetics has a negative expected return of -0.27%. Please make sure to verify Neuronetics' value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Neuronetics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.71 |
Almost perfect reverse predictability
Neuronetics has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Neuronetics time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Neuronetics price movement. The serial correlation of -0.71 indicates that around 71.0% of current Neuronetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.71 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.08 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Neuronetics Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Neuronetics reported net income of (43.73 Million). This is 112.81% lower than that of the Health Care Equipment & Supplies sector and 125.26% lower than that of the Health Care industry. The net income for all United States stocks is 107.66% higher than that of the company.
Neuronetics Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Neuronetics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Neuronetics could also be used in its relative valuation, which is a method of valuing Neuronetics by comparing valuation metrics of similar companies.Neuronetics is currently under evaluation in net income category among its peers.
Neuronetics Institutional Holders
Institutional Holdings refers to the ownership stake in Neuronetics that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Neuronetics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Neuronetics' value.| Shares | Goldman Sachs Group Inc | 2025-06-30 | 442.9 K | State Street Corp | 2025-06-30 | 427.9 K | Two Sigma Investments Llc | 2025-06-30 | 367.8 K | Boothbay Fund Management, Llc | 2025-06-30 | 337 K | Ubs Group Ag | 2025-06-30 | 318 K | Northern Trust Corp | 2025-06-30 | 275.4 K | Awm Investment Company Inc | 2025-06-30 | 245.9 K | Hightower Advisors, Llc | 2025-06-30 | 160 K | Two Sigma Advisers, Llc | 2025-06-30 | 157.4 K | Vanguard Group Inc | 2025-06-30 | 2.7 M | Blackrock Inc | 2025-06-30 | 2.2 M |
Neuronetics Fundamentals
| Return On Equity | -2.19 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.34) % | ||||
| Operating Margin | (0.20) % | ||||
| Current Valuation | 169.1 M | ||||
| Shares Outstanding | 68.49 M | ||||
| Shares Owned By Insiders | 19.12 % | ||||
| Shares Owned By Institutions | 61.83 % | ||||
| Number Of Shares Shorted | 7.16 M | ||||
| Price To Book | 3.89 X | ||||
| Price To Sales | 0.82 X | ||||
| Revenue | 74.89 M | ||||
| Gross Profit | 66.1 M | ||||
| EBITDA | (34.37 M) | ||||
| Net Income | (43.73 M) | ||||
| Cash And Equivalents | 73.7 M | ||||
| Cash Per Share | 2.71 X | ||||
| Total Debt | 82.63 M | ||||
| Debt To Equity | 0.63 % | ||||
| Current Ratio | 4.02 X | ||||
| Book Value Per Share | 0.40 X | ||||
| Cash Flow From Operations | (31 M) | ||||
| Short Ratio | 4.75 X | ||||
| Earnings Per Share | (0.83) X | ||||
| Target Price | 6.5 | ||||
| Number Of Employees | 716 | ||||
| Beta | 0.81 | ||||
| Market Capitalization | 106.84 M | ||||
| Total Asset | 140.9 M | ||||
| Retained Earnings | (419.79 M) | ||||
| Working Capital | 26.86 M | ||||
| Net Asset | 140.9 M |
About Neuronetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Neuronetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neuronetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neuronetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Will Health Care Equipment & Supplies sector continue expanding? Could Neuronetics diversify its offerings? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Neuronetics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth 1.013 | Return On Assets | Return On Equity |
Neuronetics's market price often diverges from its book value, the accounting figure shown on Neuronetics's balance sheet. Smart investors calculate Neuronetics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Neuronetics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.